Guanfacine Extended-Release Tablets 2 mg recall: Contamination
Guanfacine Extended-Release Tablets 2 mg,100-count bottles, Rx Only, Manufactured by: Apotex Inc. Toronto, Ontario Canada M9L 1T9 Manufactured for…
Why was Guanfacine Extended-Release Tablets 2 mg recalled?
Cross Contamination with Other Product: Product is being recalled due to Trace Amounts of Quetiapine Fumarate
What should I do if I have this product?
The recall is ongoing. Follow the firm and FDA instructions.
What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.
Is my product affected?
Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.
Which lot codes, UPCs or models are affected?
Lot #: RX1662, RX1663, RX1664 Exp. 11/2022
- Product
- Guanfacine Extended-Release Tablets 2 mg,100-count bottles, Rx Only, Manufactured by: Apotex Inc. Toronto, Ontario Canada M9L 1T9 Manufactured for…
- Recalling firm
- Apotex Corp.
- Quantity
- 55620 bottles
- Distribution
- Nationwide within the United States
- Recall date
- April 14, 2021
- Classification
- Class II
- Status
- Ongoing
- Agency
- FDA (drug)